Big pharma still makes billions after patents lapse
Doctors in the US are wasting hundreds of millions of dollars a year prescribing expensive branded medicines even when cheaper generic alternatives are available, according to an FT analysis. David Crow and Sujeet Indap discuss the findings. Hosted on Acast. See acast.com/privacy for more information.